KalVista Pharmaceuticals (KALV) P/E (2017 - 2026)
KalVista Pharmaceuticals (KALV) P/E from Jan 31, 2017 to Jun 12, 2026. The TTM KalVista Pharmaceuticals (KALV) P/E is -7.48. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of KalVista Pharmaceuticals (KALV)
| Year | P/E | Change |
|---|---|---|
| 2026 | -7.48 | +91.35% |
| 2025 | -3.91 | +65.91% |
| 2024 | -2.36 | -43.51% |
| 2023 | -4.17 | +130.86% |
| 2022 | -1.81 | -64.03% |
| 2021 | -5.02 | -45.08% |
| 2020 | -9.15 | -24.70% |
| 2019 | -12.15 | -26.01% |
| 2018 | -16.42 | +195.82% |
| 2017 | -5.55 | N/A |
Comparison KalVista Pharmaceuticals (KALV) P/E with competitors
KalVista Pharmaceuticals (KALV) P/E is -7.48.